Skip Ribbon Commands
Skip to main content

Keynote Speakers

 Sir Michael MARMOT
 Professor of Epidemiology,
 Public Health, University College

Sir Michael MARMOT has been Professor of Epidemiology at University College London since 1985, and is Director of the UCL Institute of Health Equity. He is the author of The Health Gap: the challenge of an unequal world (Bloomsbury: 2015), and Status Syndrome (Bloomsbury: 2004). Professor Marmot is the Advisor to the WHO Director-General, on social determinants of health, in the new WHO Division of Healthier Populations; Distinguished Visiting Professor at Chinese University of Hong Kong (2019-), and co-Director of the of the CUHK Institute of Health Equity. 

He is the recipient of the WHO Global Hero Award; the Harvard Lown Professorship (2014-2017); the Prince Mahidol Award for Public Health (2015), and 19 honorary doctorates. Marmot has led research groups on health inequalities for nearly 50 years. He chaired the WHO Commission on Social Determinants of Health, several WHO Regional Commissions, and reviews on tackling health inequality for governments in the UK. He served as President of the British Medical Association (BMA) in 2010-2011, and as President of the World Medical Association in 2015. He is President of the British Lung Foundation. He is a Fellow of the Academy of Medical Sciences and Honorary Fellow of the American College of Epidemiology and of the Faculty of Public Health; an Honorary Fellow of the British Academy; and of the Royal Colleges of Obstetrics and Gynaecology, Psychiatry, Paediatrics and Child Health, and General Practitioners. 

He is an elected member of the US National Academy of Medicine and of the Brazilian Academy of Medicine. He was a member of the Royal Commission on Environmental Pollution for six years and in 2000 he was knighted by Her Majesty The Queen, for services to epidemiology and the understanding of health inequalities.

9.30am | Keynote 1
Social Determinants of Health and Social Prescribing

 Director of Community Health
 and Personalised Care, NHS England,
 Special Advisor, National  Academy 
 for Social Prescribing (NASP)


Mr James SANDERSON is Director of Community Health and Personalised Care at NHS England where he leads on a range of programmes that are supporting people to have greater choice and control over their health and wellbeing.

Programmes include: the delivery of the comprehensive model for personalised care, NHS @home, and the National Palliative and End of Life Care Programme. In community health the NHS’s ambition is to support more people to stay well and independent at home, wherever they call home, so that they can live their best lives. 

The transformation of community health services through improving the digital and data infrastructure, and working with local systems to develop new models of care, is a key element of the NHS's recovery. These programmes include the expansion and further roll out of virtual wards, urgent community response, anticipatory care, enhanced health in care homes and intermediate care. 

From 2019-22 James was also CEO of the National Academy for Social Prescribing (NASP), established by the SofS for Health and Social Care in 2019 to advance social prescribing across the arts, health, sports, leisure, and the natural environment, alongside other aspects of our lives.

James joined NHS England in November 2015 and was formerly the Chief Executive and Accounting Officer for the Independent Living Fund (ILF). The ILF was an arm’s length body of the Department for Work and Pensions and supported disabled people across the whole of the UK to live independent lives through the provision of direct payments enabling the purchase of personal assistance support.

Prior to joining the ILF in 2002, James had a career in the motor industry within a number of sales and marketing roles, in both corporate and retail environments. James is also a performing arts graduate with a background in community theatre.

You can follow James on Twitter @JamesCSanderson.

10.00am | Keynote 2
Social Prescribing and Person-Centred Healthcare

 Director, Division of Healthy
 Environments and Populations,
 Western Pacific Region Office,
 World Health Organisation

Dr Hiromasa OKAYASU 
is the Director, Division of Healthy Environments and Populations, Regional Office for the Western Pacific, World Health Organization. He joined the WHO in 2008.  Before the current role, he served as a team leader, product development and innovation, at Polio Eradication Department, in WHO Headquarters, a Coordinator, WHO Mekong Malaria Elimination (MME) Programme, in WHO Cambodia Office and a Coordinator, Healthy Ageing in WHO Regional Office for the Western Pacific.

Prior to WHO, he has worked as a management consultant at McKinsey and Company in Tokyo, Japan and New Jersey, USA. He earned MD from Keio University, Japan (1999) and MBA from Stanford University (2005).

10.30am | Keynote 3
Social Prescribing in the Asia Pacific Region: Empowering Communities to Support Healthy Ageing

 Prof LEE Chien Earn
 Deputy Group CEO
 (Regional Health System), SingHealth

​Professor LEE Chien Earn is currently the Deputy Group CEO (Regional Health System), SingHealth where he leads population health efforts to enable residents in Eastern Singapore to keep well, get well and live well. He also chairs the Planning Committee for the upcoming Eastern General and Community HospitalsHis past appointments include CEO of Changi General Hospital, and Deputy Director of Medical Services for Health Services and Healthcare Performance in the Ministry of Health Singapore where he led the strategic development and improvement of healthcare services.

Prof Lee is an Adjunct Professor with three institutions of higher learning i.e. Saw Swee Hock School of Public Health, National University of Singapore, Duke-NUS Medical School and Singapore University of Technology and Design. He was a member of several international committees under the World Health Organisation, International Hospital Federation and Joint Commission International.

Prof Lee co-edited Singapore's Health Care System: What 50 Years Have Achieved (2015) and contributed the chapter on Strategies for Health Services in the 6th edition of the Oxford Textbook of Public Health (2015). He has also published and presented in international journals and conferences respectively.

11.00am | Keynote 4
Population Health in Singapore – A Sharper Focus
through Healthier SG


  Clinical Lead,
  Public and Population Health, Google

Dr Von NGUYEN is the Clinical Lead, Public and Population Health at Google where he supports the development of products designed to improve health. He has extensive experience in the private sector designing, implementing, and evaluating large value-based care programs where physicians are incentivized to focus on prevention and the proactive management of disease. He has also served in senior roles at the Centers for Disease Control and the Centers for Medicare and Medicaid Services within the U.S. Government where he worked on health policy, public health, and population health. Von is a primary care physician and epidemiologist. 

4.00pm | Keynote 5
Using Technology to Improve Population Health

  A/Prof Kate MULLIGAN
  Canadian Institute for Social Prescribing,
  Dalla Lana School of Public Health
  University of Toronto

Assistant Professor Kate MULLIGAN leads the Canadian Institute for Social Prescribing (CISP) and is an Assistant Professor in Social and Behavioural Health Sciences in the Dalla Lana School of Public Health at the University of Toronto. She is also the senior advisor to the Canadian Red Cross on knowledge mobilization and determinants of health, and a public member of the Toronto Board of Health. Her work focuses on community leadership in health.

Find Kate on Twitter @KateMMulligan and the Canadian Institute for Social Prescribing @CISP_ICPS.

4.30pm | Keynote 6
Social Prescribing Advocacy Across Stakeholders

Ms Margaret Lee
Chief Executive Officer, 
SingHealth Community Hospitals

Ms Margaret LEE has more than 25 years of experience in the Singapore public healthcare system, with expertise in healthcare management, finance and corporate services development. 

As the Chief Executive Officer of SCH, Ms Lee stewards the organisation's efforts in establishing itself as a leading provider of sub-acute and rehabilitation care. Her guidance drives staff to adopt new care models and deliver person-centred care to achieve patients' health goals. Ms Lee also engages staff to foster an environment conducive for best practices and corporate governance, while maintaining financial effectiveness and sustainability.

Prior to her current appointment, Ms Lee was the Group Chief Financial Officer of the then-newly-formed National University Health System. She also served as Finance Director of National University Hospital, where she was pivotal in implementing IT systems and financial frameworks, and leading a successful financial turnaround.

She was a member of the National Clinician Remuneration Committee and sub-committee as well as various finance project committees set up by the Ministry of Health Holdings. Ms Lee is also SingHealth's Deputy Group Chief Financial Officer (Regional Health System and Strategic Finance), a Fellow of the Institute of Singapore Chartered Accountants and a member of the Board of Trustees of Singapore University of Social Sciences.

5.00pm | Closing Plenary
Change Management for Social Prescribing